US Patent Issued to Novartis on Sept. 9 for "Natriuretic peptide receptor 1 antibodies and methods of use" (German, American, Swiss Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,255, issued on Sept. 9, was assigned to Novartis AG (Basel, Switzerland).

"Natriuretic peptide receptor 1 antibodies and methods of use" was invented by John Louis Diener (Cambridge, Mass.), Lars Gadtke (Munich), Felix Hartlepp (Munich), Tiancen Hu (Woodbridge, Conn.), Kathrin Ladetzki-Baehs (Planegg, Germany), Michael John Romanowski (Lexington, Mass.), Cesare Russo (Bachlettenstrasse, Switzerland), Xenia Wezler (Munich) and Xiaoling Xie (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to anti-Natriuretic Peptide Receptor 1 (NPR1) antibodies including agonist antibodies which are able to activate the NPR1 re...